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Abstract: Nonalcoholic steatohepatitis (NASH) is one of the leading causes of chronic liver disease 
worldwide. However, details of pathogenetic mechanisms remain unknown. Deletion of both p62/
Sqstm1 and Nrf2 genes spontaneously led to the development of NASH in mice fed a normal chow 
and was associated with liver tumorigenesis. The pathogenetic mechanism (s) underlying the NASH 
development was investigated in p62:Nrf2 double-knockout (DKO) mice. DKO mice showed massive 
hepatomegaly and steatohepatitis with fat accumulation and had hyperphagia-induced obesity coupled 
with insulin resistance and adipokine imbalance. They also showed dysbiosis associated with an 
increased proportion of gram-negative bacteria species and an increased lipopolysaccharide (LPS) 
level in feces. Intestinal permeability was elevated in association with both epithelial damage and 
decreased expression levels of tight junction protein zona occludens-1, and thereby LPS levels were 
increased in serum. For Kupffer cells, the foreign body phagocytic capacity was decreased in magnetic 
resonance imaging, and the proportion of M1 cells was increased in DKO mice. In vitro experiments 
showed that the inflammatory response was accelerated in the p62:Nrf2 double-deficient Kupffer 
cells when challenged with a low dose of LPS. Diet restriction improved the hepatic conditions of 
NASH in association with improved dysbiosis and decreased LPS levels. The results suggest that in 
DKO mice, activation of innate immunity by excessive LPS flux from the intestines, occurring both 
within and outside the liver, is central to the development of hepatic damage in the form of NASH.
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Introduction
nonalcoholic steatohepatitis (nAsh) is a progressive 
liver disease characterized by steatosis, inflammation, 
and fibrosis leading to liver cirrhosis and cancer [3]. 
nAsh, a hepatic representation of metabolic syndrome, 
is an increasingly common health problem globally [40].
it is unlikely that the pathogenesis of nAsh is depen-
dent upon any single factor, and it is likely that nAsh 
is the result of multiple factors, including obesity/insulin 
resistance-mediated steatosis, intestinal-derived lipo-
polysaccharides (LPs), oxidative stress, lipotoxicity, and 
other conditions that promote inflammation, fibrosis, and 
hepatocyte death [7, 38]. The molecular mechanisms 
corresponding to these pathogenic processes are poorly 
understood.
p62/A170/sqstm1 is a cytoplasmic endosome-associ-
ated protein that acts as a scaffold for atypical protein 
kinase C [17]. Recently, p62 was reported to play an 
important role in selective autophagy of ubiquitin-bind-
ing protein [24, 35]. p62-knockout (p62-KO) mice de-
velop mature-onset obesity after progressing to insulin 
and leptin resistance when fed a standard diet [33]. In a 
previous study, hyperphagia (overeating) was reported 
to be the primary cause of obesity in p62-KO mice and 
was found to be associated with a disruption in leptin 
signaling [12].
nuclear factor E2-related factor-2 (nrf2), a transcrip-
tion factor, is a master regulator of the cellular adaptive 
response to oxidative stress [19, 23, 37]. Nrf2-knockout 
(Nrf2-KO) mice exhibit a severe deficiency in the gene 
regulatory program for the antioxidant response, result-
ing in high susceptibility to oxidative stress-related 
disorders and chemical carcinogenesis [20]. In a previous 
study, Nrf2-KO mice were found to be prone to develop-
ing NASH/fatty liver disease when fed a diet deficient 
in methionine and choline [32]. It is reported that activa-
tion of nrf2 prevents LPs-induced transcriptional up-
regulation of pro-inflammatory cytokines, including 
interleukin (Il)-6 and IL-1β [22].
recent animal models of nAsh include a diet-induced 
rat model developed by administration of a methionine- 
and choline-deficient diet and hepatocyte-specific Pten-
deficient mice [15, 45]. However, these animal models 
show an unnatural decrease in body weight and rapid 
progression of symptoms, and there is the possibility that 
they deviate from human nAsh. The lack of compara-
tive animal models is a major reason for why the patho-
genic mechanisms of NASH have not been clarified, and 
the development of a novel model is required.
In the current study, we developed a p62:Nrf2 gene 
double-knockout (dKO) mouse by crossing a p62-KO 
mouse and an Nrf2-KO mouse and investigated possible 
new mechanisms associated with the deletion of both 
p62 and Nrf2 genes in the pathogenesis of nAsh. it is 
likely that p62 and Nrf2 deficiency plays a variety of 
pathogenic roles in a number of organs and/or tissues 
that form a basis for nAsh onset and progression 
through a linkage between organs and tissues. We found 
that the dKO mouse is a novel animal model of nAsh.
Materials and Methods
Animal studies
All experiments were performed under protocols ap-
proved by the institutional Animal Care and use Com-
mittees of the University of Tsukuba. Except where in-
dicated in this paper or cited in the respective 
references, animals were bred and maintained under 
standard housing conditions with ad libitum access to 
food (mF: 5.1% fat, 23.1% protein, 360 kcal/100 g; Ori-
ental Yeast, Tokyo, Japan) and water. They were housed 
at an ambient temperature of 20–23°C on a daily 12-h 
light/dark cycle with 30–70% relative humidity and were 
weaned from their mothers between 3–4 weeks of age. 
All mice were kept under specific pathogen-free condi-
tions in an environmentally controlled clean room at the 
Laboratory Animal resource Center, university of Tsu-
kuba.
The mice used were 8-, 30-, and 50-week-old male 
wild-type (WT) C57BL/6J mice obtained from Charles 
Laboratories Japan (Kanagawa, Japan) and bred in our 
own colony. p62-KO and Nrf2-KO mice were generated 
and genotyped as previously described [18, 24]. DKO 
mice were produced by crossing these mutant mice and 
regenotyped. Before analysis, mice were crossed with 
C57bL/6J mice for>10 generations to produce fertile 
offspring that grew normally. Male mice were used in all 
experiments. In pair-feeding experiments, one 3-week-
old DKO pup was weaned in a separate cage and given 
a portion of standard diet (3.0 ± 0.1 g) per day until 25 
weeks of age [12]. In probiotics experiments, DKO mice 
were administered probiotics (VSL#3, VSL Pharmaceu-
ticals, Gaithersburg, MD, USA) from 10 weeks of age 
and observed at 25 weeks of age. VSL#3 was dissolved 
in drinking water (4.5 billion colonies/ml).
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Glucose tolerance test
Mice were fasted for 13 h before intraperitoneal injec-
tion of glucose (1 g/kg body weight). A drop of blood 
drop was taken from the tail after 15, 30, 60, and 120 
min. The tail tip was cut 2 mm from the end, and the tail 
was pressed to collect a drop of blood at the indicated 
time. Glucose levels were measured using a portable 
glucose meter (Ascensia, bayer healthCare, berlin, 
germany).
Biochemical analyses
Serum glucose was detected using a glucose CII test 
kit (Wako, Tokyo, Japan). Serum insulin was measured 
using a mouse insulin ELISA kit (Morinaga, Kanagawa, 
Japan). Serum leptin was measured using a mouse/rat 
leptin ELISA kit (Morinaga, Kanagawa, Japan). Adipo-
nectin was measured in serum using a Mouse Adiponec-
tin/Acrp30 Quantikine ELisA Kit (r&d systems, min-
neapolis, mn, usA). The homeostatic model assessment 
for insulin resistance (HOMA-IR) was determined by 
performing the following calculation: HOMA-IR=fasting 
plasma insulin (mu/l) × fasting blood glucose (mg/
dl)/405.
Histological analysis
Liver, intestine, and adipose tissues were fixed in 4% 
paraformaldehyde and embedded in paraffin, and 2 µm-
thick tissue sections were stained with hematoxylin-
eosin (h&E) and sirius red solution. For immunostaining 
of 4-hydroxy-2-nonenal (4-HNE), sections were stained 
using the indirect immunoperoxidase method with anti-
4hnE monoclonal antibodies (Ab) (JaiCA, shizuoka, 
Japan). For immunostaining of glutathione s-transferase 
P1, tissue sections were immunostained with mAb 
(bmL, Tokyo, Japan). To determine the histopathologi-
cal lesions in nonalcoholic fatty liver disease, the ste-
atosis, activity, and fibrosis (SAF) score were assessed 
separately for the grade of steatosis (from s0 to s3), the 
activity (from A0 to A4 by adding grades of ballooning 
and lobular inflammation, both from 0 to 2), and the stage 
of fibrosis (from F0 to F4) [2]. Histological changes in 
the intestines were evaluated and graded by a blinded 
evaluator as follows: 0 (normal), no damage; 1 (mild), 
slight submucosal and/or lamina propria separation; 2 
(moderate), moderate separation of the submucosa and/
or lamina propria and/or edema in the submucosa and 
muscular layers; 3 (severe), severe separation of the 
submucosa and/or lamina propria and/or severe edema 
in the submucosa and muscular layers with regional vil-
lous sloughing; and 4 (necrosis), loss of villi and necro-
sis [28].
LPS levels
Concentrations of LPS in plasma and feces were 
evaluated using a Pyrochrome limulus amebocyte lysate 
assay (Associates of Cape Cod, East Falmouth, mA, 
usA). LPs levels are expressed as Endotoxin units 
(Eu).
Fecal bacterial analysis
Stool samples were collected from mice, snap-frozen 
and stored at −80°C until use. DNA extraction from fe-
cal samples and analysis of the fecal microbiota using a 
16s rdnA library and terminal restriction fragment 
length polymorphisms were outsourced to TechnoSu-
ruga Laboratory Co., Ltd. (shizuoka, Japan). Preparation 
of the fecal microbiota using a 16s rrnA gene amplicon 
library and analysis of 16s rrnA gene amplicon se-
quencing were outsourced to FASMAC Co., Ltd. 
(Kanagawa, Japan).
Magnetic resonance imaging (MRI) analyses
For analysis of Kupffer cells phagocytosis, MRI was 
performed using a 1T animal scanner (mrTechnology, 
ibaraki, Japan). region-of-interest measurements of T2 
values were performed on consecutive pre- and super-
paramagnetic iron oxide (sPiO) administration.
Evaluation of microsphere phagocytosis
Prior to 5 min of liver perfusion, latex beads (1.0 µm 
diameter, carboxylate-modified; FluoSpheres®, Thermo 
Fisher Scientific, Waltham, MA, USA) at 0.57 µl/g body 
weight were injected into the tail vein. Following liver 
perfusion, cells were isolated. The Kupffer cell surface 
marker F4/80 was stained. The percentage of phago-
cytic cells and the fluorescence intensity of latex beads 
in F4/80-positive cells were evaluated by flow cytometry.
Flow cytometric analysis
Kupffer cells were stained with APC-conjugated anti-
F4/80 Ab (Thermo Fisher Scientific, Waltham, MA, 
usA), PerCP/Cy5.5 anti-mouse Cd206 Ab (bioLegend, 
san diego, CA, usA), PE anti-mouse Cd11c Ab (bio-
legend, CA, USA), anti-macrophage receptor with col-
lagenous structure (mArCO) Ab (bio-rad, hercules, 
CA, usA), and anti-class A macrophage scavenger re-
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ceptor (sr-A) Ab (r&d systems, minneapolis, mn, 
USA) with Alexa Fluor 488 (Thermo Fisher Scientific, 
Waltham, MA, USA). Flow cytometry was performed 
using a Gallios flow cytometer (Beckman Coulter, Brea, 
CA, usA).
Intestinal permeability assay
To evaluate epithelial permeability in the intestines, 
mice underwent gavage with nondigestible 4 kDa fluo-
rescein isothiocyanate (FiTC)-dextran (sigma-Aldrich, 
St. Louis, MO, USA) at a dose of 0.5 mg/g body weight 
after fasting for 13 h. serum (50 µl) was collected from 
the fundus at various time points (0, 1, 2, 3, and 6 h), 
and the intensity of FITC in serum was measured using 
an imark plate reader (bio-rad, hercules, CA, usA) 
with excitation at 488 nm. Data were plotted against the 
standard curve of serial dilutions of FiTC-dextran.
Immunoblot analysis
After extraction from mouse samples or cultured cells, 
each protein sample was subjected to SDS/PAGE and 
transferred to a PVDF membrane (Bio-Rad, Hercules, 
CA, usA). Then the corresponding primary and second-
ary antibodies were incubated to visualize the protein. 
All antibodies used in this study are listed in supple-
mentary Table 1.
Quantitative real-time polymerase chain reaction (qRT-
PCR)
Total RNA was extracted from specimens or cultured 
cells, followed by cDNA synthesis. qRT-PCR was per-
formed with Fast SYBR Green Master Mix (Thermo 
Fisher Scientific, Waltham, MA, USA). Data were nor-
malized to the amount of glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) present in each sample and 
then averaged. supplementary Table 2 provides a list of 
all the primers used in this study.
In vitro tissue culture studies and cell lines
Mouse primary Kupffer cells from 8- to 10-week-old 
male WT, Nrf2-KO, p62-KO, and DKO mice were iso-
lated via portal vein collagenase treatment (Worthington 
Biochemical, Lakewood, NJ, USA) followed by cen-
trifugation and cell sorting. For Kupffer cell sorting, cells 
were incubated with APC-conjugated anti-F4/80 Abs 
(Thermo Fisher Scientific, Waltham, MA, USA) for 30 
min. Cells were sorted into F4/80+ subpopulations using 
a beckman Coulter moFlo XdP cell sorter and imme-
diately processed for rnA isolation.
The murine monocyte/macrophage cell line rAW264.7 
was obtained from ATCC. The human colon cancer cell 
line Caco-2 was purchased from RIKEN BRC (Ibaraki, 
Japan). Cells were cultured at 37°C under 5% CO2 in 
high glucose Dulbecco’s modified Eagle’s medium con-
taining 4.5 g/l glucose, 1% penicillin-streptomycin, 10% 
fetal bovine serum, and 1% nonessential amino acids 
(only in Caco-2).
Knockout of p62 and Nrf2 genes using the CRISPR-Cas9 
system
The detailed instructions of a published protocol were 
followed to knock out p62 and Nrf2 genes using the 
CRISPR-Cas9 system [5]. Briefly, 20 bp target single-
guide RNA sequences were obtained by screening p62 
and Nrf2 mrnA sequences using the CrisPr design 
online software (http://crispr.mit.edu/). After annealing, 
short double-strand DNA was ligated using the Bbsi 
digested pX330 plasmid. rAW264.7 and Caco-2 cells 
were transfected with individual pX330 gDNA using the 
neon Transfection system.
Measurement of transepithelial electrical resistance 
(TER)
Caco-2 cells were seeded into a polyethylene tere-
phthalate membrane with 0.4 µm pores. The medium 
was changed every other day until complete differentia-
tion. Electrical resistance was measured using a Milli-
cell-Ers electrical resistance system (Emd millipore, 
billerica, mA, usA). TEr values are expressed as 
Ω·cm2. Measurements were performed on three repli-
cates in three independent experiments. in the LPs ex-
periments, cell monolayers were treated with 100 EU /
ml LPS for 3 or 6 h, and TER was measured.
Statistical analysis
Statistical analysis was conducted using IBM SPSS 
Statistics 22.0 (IBM, Armonk,, NY, USA). Values are 
expressed as the mean ± SE. When two groups were 
compared, the unpaired t-test was used for data analysis. 
Multiple-group comparisons were performed using one-
way analysis of variance (ANOVA). A P-value<0.05 was 
considered statistically significant.
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Results
DKO mice fed a normal chow diet exhibited hyperphagia, 
obesity, insulin resistance, and adipokine imbalance
DKO mice were negative for p62 and Nrf2 protein 
expression in the liver (Fig. 1A). The body weights of 
WT, Nrf2-KO, p62-KO, and dKO mice fed a normal 
chow diet were monitored over a 42-week period in mice 
8–50 weeks of age. Mice lacking p62 and/or Nrf2 genes 
were viable and had similar body weights at birth. There-
after, p62-KO and DKO mice gained weight much 
faster than WT and Nrf2-KO mice (Fig. 1B). At 30 weeks 
of age, the body weights for each genotype were 37.8 ± 
1.3 g for WT, 37.6 ± 1.0 g for Nrf2-KO, 49.7 ± 1.3 g for 
p62-KO, and 46.5 ± 0.6 g for DKO. Liver mass was 
significantly increased in DKO mice compared with in 
WT mice (Supplementary Fig. 1A) but was less than that 
in p62-KO mice. using computed tomography, percent-
ages of body fat and visceral fat weight were observed 
to increase in p62-KO and dKO mice (supplementary 
Fig. 1b). WT and Nrf2-KO mice showed only a slight 
increase in food intake with age, with the average intake 
at 8 weeks being 3.0 g/day/mouse. In contrast, food in-
take of p62-KO and dKO mice increased from 3.3 g/
day/mouse at 8 weeks of age to 4.0 g/day/mouse at 30 
weeks of age (Fig. 1C).
in comparisons of blood biochemistry versus the WT 
mice, DKO mice showed the development of hypergly-
cemia and a tendency towards increased fasting insulin 
levels and homeostatic model assessment for insulin 
resistance (hOmA-ir). Of note, dKO mice exhibited 
insulin resistance at 8 weeks of age (Fig. 1D). In addi-
tion, dKO mice exhibited glucose intolerance in an in-
traperitoneal glucose tolerance test (Fig. 1E). serum 
leptin levels in p62-KO and dKO mice increased sig-
nificantly from 8 weeks to 30 weeks of age compared 
with WT and Nrf2-KO mice. serum adiponectin levels 
in p62-KO and DKO mice decreased significantly (Fig. 
1F).
Collectively, the results indicated that dKO mice de-
veloped hyperphagia and obesity (visceral fat accumula-
tion) and exhibited insulin resistance and adipokine 
imbalance.
DKO mice fed a normal chow diet developed NASH and 
liver tumors
The time course of changes in liver histology for WT, 
Nrf2-KO, p62-KO, and DKO mice are shown in Figs. 
2A, 2b, and supplementary Fig. 2A p62-KO and dKO 
mice exhibited steatosis at 30 weeks of age (Fig. 2C). 
DKO mice showed a marked increase in infiltration of 
inflammatory cells in the liver compared with WT mice 
(Fig. 2D). Hepatic fibrosis significantly increased in 
dKO mice (Fig. 2E). in contrast, no marked increase in 
hepatic fibrosis was observed in Nrf2-KO and p62-KO 
mice (Fig. 2E). The extent of fibrosis was confirmed by 
Masson’s trichrome staining and was closely associated 
with hepatic fibrosis (Fig. 2F). While steatosis, activity, 
and fibrosis (SAF) scores increased in Nrf2-KO and p62-
KO mice, scores showed greater increases in DKO mice 
(Fig. 2C-E). Immunostaining with 4-HNE was performed 
to determine the presence of lipid peroxides. increased 
staining was observed in the livers of DKO mice at 30 
weeks of age but not in Nrf2-KO and p62-KO mice 
(supplementary Fig. 2b).
Tumor formation was observed in the livers of DKO 
mice. Macroscopic liver tumors were observed in 12% 
(8/66) of DKO mice by 50 weeks of age (Fig. 2G). No 
tumors were observed in Nrf2-KO and p62-KO mice. 
Microscopic findings revealed that tumors were com-
prised of cellular masses with nuclear atypia, included 
lipid droplets in some cells, and were partially surround-
ed by a fibrous cap. Intense glutathione S-transferase P1 
staining was observed in whole sections of tumors.
With regard to visceral fat tissue, crown-like structures 
of inflammatory cells, comprising macrophages sur-
rounding dead or dying adipocytes (a histologic hallmark 
of the pro-inflammatory process), were observed in p62-
KO and DKO mice, with greater inflammatory cell in-
filtration being observed in DKO mice (Supplementary 
Fig. 2C).
Hepatic expression levels of tumor necrosis factor-α 
(Tnf-α), IL-1β, IL-6, and toll-like receptor 4 (Tlr4) 
mRNA increased in DKO mice at 8 and 30 weeks of age 
compared with WT mice. mRNA levels of transforming 
growth factor-β1 (Tgf-β1) and procollagen-α1, both of 
which are closely associated with hepatic fibrosis, in-
creased in DKO mice at 30 weeks of age (Table 1). Vis-
ceral fat expression levels of IL-1β mRNA significantly 
increased in DKO mice at 8 weeks of age. mRNA levels 
of Tnf-α, IL-1β, Tlr4, monocyte chemoattractant protein 
1 (Mcp-1), CD14, and Tgf-β1 increased in dKO mice at 
30 weeks of age compared with WT mice (Table 1).
These results suggested that DKO mice first developed 
liver inflammation at an early age prior to obesity and 
then developed NASH and liver tumors with aging.
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Modified microbiota composition and fecal LPS content 
in DKO mice
Fecal microbiota composition was determined in DKO 
mice at 30 weeks of age. Analysis was conducted using 
culture-independent PCR amplification of the variable 
4 region of bacterial 16S rRNA genes followed by Il-
lumina sequencing. Principal coordinates analysis of the 
weighted UniFrac distance between samples revealed 
Fig. 1. p62:Nrf2 gene double-knockout (DKO) mice fed a normal chow diet exhibited hyperphagia, obesity, insulin resistance, and 
adipokine imbalance. (A) Immunoblot analysis of Nrf2 and p62 in livers of wild-type (WT), Nrf2-knockout (KO), p62-KO, and 
DKO mice at 8 weeks of age. (B) Body weight changes in WT, Nrf2-KO, p62-KO, and DKO mice (n=10–15 per group). (C) 
Food intake, (d) fasting blood glucose concentration, fasting serum insulin concentration, and homeostatic model assessment 
for insulin resistance (HOMA-IR) (n=8 per group) at 8 and 30 weeks of age. (E) Glucose tolerance tests were performed after 
mice were fasted for 13 h at 8 and 30 weeks of age (n=7–9 per group). (F) Serum leptin and adiponectin concentrations at 8 and 
30 weeks of age (n=8 per group). Results are presented as the mean ± SE. *P<0.05, significantly different from the WT group; 
†P<0.05, significantly different from the Nrf2-KO group; §P<0.05, significantly different from the p62-KO group.
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Fig. 2. p62:Nrf2 gene double-knockout (dKO) mice developed nonalcoholic steatohepatitis and liver tumors. (A) hematoxylin and 
eosin (H&E)-stained sections of representative liver specimens from wild-type (WT), Nrf2-knockout (KO), p62-KO, and dKO 
mice at 8 and 30 weeks of age. Arrowheads indicate infiltration of inflammatory cells (scale bar, 100 µm). (b) sirius red-stained 
sections. (C–E) The steatosis, activity, and fibrosis (SAF) scores for each group are shown (n=8 per group). (F) Fibrotic areas 
in livers of WT, Nrf2-KO, p62-KO, and DKO mice (n=8 per group). (G) Representative liver tumors in DKO mice. Macro-
scopic view of tumors (upper panel), an H&E-stained section (middle panel; T, tumor part; NT, non-tumor part), and a glutathi-
one S-transferase P1-stained section of the tumor (lower panel) (scale bar, 100 µm). The inset areas show magnified views of 
part of the tumor in the middle panels (scale bar, 10 µm). results are presented as the mean ± sE. *P<0.05, significantly differ-
ent from the WT group; †P<0.05, significantly different from the Nrf2-KO group; §P<0.05, significantly different from the p62-
KO group.
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that the microbiota composition was profoundly modi-
fied in DKO mice (Fig. 3A). Whereas gram-positive 
bacteria were the major representative signature opera-
tional taxonomic unit accounting for the differences in 
intestinal microbiota composition in WT mice, gram-
negative bacteria were the predominant signature op-
erational taxonomic unit in p62-KO and dKO mice (Fig. 
3b). The Porphyromonadaceae and Paraprevotellaceae 
families were more abundant in DKO than in WT mice, 
and the Lachnospiraceae and Ruminococcaceae families 
were less abundant in DKO mice (Fig. 3C).
LPS is the predominant cause of liver inflammation 
in NASH patients [4, 46]. Therefore, fecal and serum 
levels of LPS were determined in mice. Correlating with 
the microbiota composition, fecal LPs concentrations 
were higher in p62-KO and dKO mice than in WT mice 
(Fig. 3D), but serum LPS concentrations were higher 
only in dKO mice (Fig. 3E).
Intestinal permeability increased in DKO mice
Previous studies have reported that increased intesti-
nal permeability is observed more frequently in nAsh 
patients [30, 34]. In the current study, intestinal tissue 
sections from WT, Nrf2-KO, p62-KO, and dKO mice 
were stained with hematoxylin and eosin, and epithelial 
damage was scored according to the histology. There 
was marked damage to intestinal epithelial morphology 
in DKO mice compared with WT mice. At 30 weeks, 
damage scores increased in Nrf2-KO and p62-KO mice, 
but they increased to a greater extent in dKO mice (Fig. 
4A). measurement of intestinal permeability by absorp-
tion of FITC-dextran showed prominent enhancement 
in Nrf2-KO and DKO mice compared with WT at 8 
weeks of age. Permeability in DKO mice was further 
increased at 30 weeks of age (Fig. 4B).
intestinal permeability is regulated by tight junctions 
formed between intestinal epithelial cells at most apical 
areas of the epithelium. Expression levels of the tight 
junction protein zona occludens-1 (Zo-1) were evalu-
ated by immunoblotting of intestinal tissue lysates from 
dKO mice. Expression levels of zo-1 decreased in the 
intestines of Nrf2-KO and DKO mice compared with 
WT mice (Fig. 4C). Expression levels of Claudin 1 and 
Claudin 2 were not significantly different among the 
groups of mice (data not shown). mRNA expression 
levels of intestinal Zo-1, Claudin 1, and Claudin 2 were 
also not significantly different (Supplementary Fig. 3A).
To investigate the effects of p62 or Nrf2 deficiency on 
intestinal barrier function, an in vitro model in which 
Caco-2 epithelial cells were grown in monolayers was 
constructed. using the CrisPr-Cas9 system, Caco-2 
cells lacking the p62 or Nrf2 gene were also constructed. 
Expression of p62 and Nrf2 protein in each gene-defi-
cient cell was confirmed by immunoblotting (Fig. 4D). 
TEr is an indicator of epithelial paracellular permeabil-
ity to ionic solutes and was used to assess intestinal bar-
Table 1. relative mrnA expression levels determined by qPCr for pathophysiological factors in the liver and visceral fat tissue of mice 
at 8 and 30 weeks of age
Age 8 weeks 30 weeks
genes WT Nrf2-KO p62-KO dKO WT Nrf2-KO p62-KO dKO
Liver
Tnf-α 1.00 ± 0.10 1.11 ± 0.17 1.60 ± 0.07 a 3.09 ± 0.84 ab 2.47 ± 0.79 3.02 ± 0.70 4.25 ± 0.37 ab 5.43 ± 1.01 ab
IL-1β 1.00 ± 0.17 0.85 ± 0.08 2.69 ± 0.31 ab 3.52 ± 0.41 ab 1.68 ± 0.26 2.02 ± 0.15 3.19 ± 0.36 ab 4.18 ± 0.32 ab
IL-6 1.00 ± 0.25 1.27 ± 0.07 2.99 ± 0.32 ab 2.49 ± 0.28 ab 1.39 ± 0.57 0.97 ± 0.32 2.66 ± 0.77 ab 4.14 ± 0.96 ab
Tlr-4 1.00 ± 0.17 1.16 ± 0.06 1.09 ± 0.09 1.43 ± 0.12 abc 1.69 ± 0.23 1.82 ± 0.29 4.02 ± 0.35 ab 3.84 ± 0.43 ab
Tgf-β1 1.00 ± 0.15 1.07 ± 0.08 0.86 ± 0.05 1.35 ± 0.15 0.97 ± 0.71 0.98 ± 0.36 1.49 ± 0.61 1.82 ± 0.72 ab
Procollagen-α1 1.00 ± 0.16 1.26 ± 0.23 0.83 ± 0.13 1.24 ± 0.19 1.14 ± 0.73 1.30 ± 0.65 1.88 ± 0.39 2.27 ± 0.79 a
Visceral fat
Tnf-α 1.00 ± 0.10 1.17 ± 0.27 0.80 ± 0.10 1.30 ± 0.30 1.15 ± 0.26 1.23 ± 0.45 2.48 ± 0.22 5.72 ± 0.78 abc
IL-1β 1.00 ± 0.16 1.47 ± 0.61 1.60 ± 0.34 4.10 ± 0.86 abc 1.92 ± 0.52 6.92 ± 2.14 4.20 ± 1.22 32.26 ± 12.83 abc
Tlr-4 1.00 ± 0.06 0.93 ± 0.16 0.88 ± 0.11 0.81 ± 0.02 0.90 ± 0.08 0.98 ± 0.15 0.89 ± 0.08 1.66 ± 0.18 abc
Mcp-1 1.00 ± 0.11 2.26 ± 0.54 1.40 ± 0.20 1.75 ± 0.46 1.09 ± 0.12 1.31 ± 0.38 3.70 ± 1.11 15.55 ± 4.84 abc
Cd14 1.00 ± 0.18 0.64 ± 0.17 0.65 ± 0.13 0.48 ± 0.06 0.63 ± 0.04 0.70 ± 0.10 0.99 ± 0.27 3.29 ± 0.99 abc
Tgf-β1 1.00 ± 0.12 0.91 ± 0.13 0.85 ± 0.06 0.79 ± 0.07 0.65 ± 0.04 0.81 ± 0.14 0.82 ± 0.12 1.68 ± 0.15 abc
mRNA expression levels were normalized using the values of the WT group at 8 weeks of age. Values are presented as the mean ± SE 
(n=8 per group). aP<0.05, significantly different from the WT group; bP<0.05, significantly different from the Nrf2-KO group; cP<0.05, 
significantly different from the p62-KO group. dKO, p62:Nrf2 gene double-deficient mice; Tnf, tumor necrosis factor; Tlr, toll-like recep-
tor; Mcp, monocyte chemotactic protein; Cd, cluster of differentiation; Tgf, transforming growth factor.
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rier function. Compared with WT cells, TER was con-
sistently decreased in Nrf2-deficient cells (Fig. 4E). The 
results of immunoblotting showed that the expression of 
zo-1 and Claudin 1 protein decreased in Nrf2-deficient 
cells compared with WT cells (Fig. 4F). Zo-1 mrnA 
expression levels decreased in Nrf2-deficient cells. Clau-
din 1 mRNA expression levels were not significantly 
different (Supplementary Fig. 3B).
because LPs causes intestinal barrier dysfunction, an 
in vitro model in which Caco-2 epithelial cells were 
grown in monolayers was treated with LPS. Compared 
with vehicle-treated cells, TER was consistently de-
creased in LPs-treated WT, Nrf2-deficient, and p62-
deficient cells at 3 h and 6 h, indicating disruption of the 
barrier function in the monolayers (Fig. 4E). Of note, 
Nrf2-deficient cells potently inhibited the reduction in 
TER caused by treatment with LPS at all time points 
(Fig. 4E).
Changes in Kupffer cell phenotype in DKO mice
Macrophage polarization is a process by which mac-
rophages express different functional programs in re-
sponse to microenvironmental signals [29]. In the livers 
of DKO mice at 8 weeks of age, M1 phenotype Kupffer 
Fig. 3. p62:Nrf2 gene double-knockout (DKO) mice showed a modified microbiota composition and increased fecal lipopoly-
saccharide (LPS) levels. (A) Principal coordinates analysis of the fecal microbiota from wild-type (WT), Nrf2-knock-
out (KO), p62-KO, and DKO mice at 30 weeks of age. (B) The relative abundance of gram-negative bacteria was 
calculated as the percentage of bacteria relative to the total bacteria for fecal bacteria (n=8 per group). (C) The relative 
abundance of families of bacteria in feces was examined. The relative abundance was calculated as the percentage of 
the bacterial subgroup relative to the total bacteria. (D) Fecal LPS levels in mice (n=8 per group). (E) Serum LPS 
levels in mice (n=8 per group). Results are presented as the mean ± SE. *P<0.05, significantly different from the WT 
group; †P<0.05, significantly different from the Nrf2-KO group; §P<0.05, significantly different from the p62-KO group.
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Fig. 4. intestinal permeability increased in p62:Nrf2 gene double-knockout (dKO) mice. (A) hematoxylin and eosin (h&E)-stained 
sections of representative intestine specimens from wild-type (WT), Nrf2-knockout (KO), p62-KO, and dKO mice at 8 and 30 
weeks of age (left panel) (scale bar, 100 µm). Histological scores for intestinal epithelia (right panel) (n=8 per group). (B) Area 
under the plasma concentration curve of fluorescein isothiocyanate (FITC)-dextran after administration of the marker by gavage 
(n=8 per group). (C) Immunoblot analysis of zona occludens-1 (Zo-1) in the intestines of WT, Nrf2-KO, p62-KO, and dKO mice 
at 8 weeks of age and quantification of immunoblotting of Zo-1 normalized to actin in mice (n=5 per group). (D) Immunoblot 
analysis of nrf2 and p62 in Caco-2 cells of WT, Nrf2-KO, and p62-KO. (E) Barrier function was analyzed by transepithelial 
electrical resistance (TER). Caco-2 cells were stimulated with 100 EU/ml lipopolysaccharide (LPS) (EU, endotoxin units). TER 
was tested at different time points (n=5 per group). (F) Quantification of immunoblotting of Zo-1, claudin 1, and claudin 2 nor-
malized to actin in Caco-2 cells (n=5 per group). Results are presented as the mean ± SE. *P<0.05, significantly different from 
the WT group; †P<0.05, significantly different from the Nrf2-KO group; §P<0.05, significantly different from the p62-KO group.
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Fig. 5. Change in Kupffer cell phenotype in p62:Nrf2 gene double-knockout (dKO) mice. (A) Cd11c and Cd206 expression in F4/80+ 
cells (Kupffer cells) in the liver. Numbers in panels and quadrants are percentages of the indicated populations. (B) Kupffer cell 
phagocytic function was determined by superparamagnetic iron oxide (SPIO) magnetic resonance imaging (MRI). The SPIO 
signal was calculated by MRI (reflecting the T2 value), and then the phagocytic function was evaluated. (C) Phagocytic activ-
ity of F4/80+ cells in the liver. isolated liver F4/80+ cells were incubated with fluorescein isothiocyanate (FITC) microspheres, 
and then FITC microsphere-positive cells were analyzed. MARCO and SR-A expression in F4/80+ cells in the liver. (d) im-
munoblot analysis of Nrf2 and p62 in RAW264.7 cells of wild-type (WT), Nrf2-knockout (KO), p62-KO, and dKO. (E) im-
munoblot analysis of phosphorylated nF-kb p65 (p-nF-kb p65) and total nF-kb p65 in rAW264.7 cells of WT, Nrf2-KO, 
p62-KO, and DKO and quantification of immunoblotting of p-NF-kB p65 normalized to total NF-kB p65. Cells were stimu-
lated with 10 EU/ml lipopolysaccharide (LPS) (EU, endotoxin units). Quantification of immunoblotting of p-NF-kB p65 normal-
ized to total nF-kb p65. (F) relative mrnA expression levels of Tnf-α and IL-1β mRNA in RAW264.7 cells (n=5 per group). 
mRNA expression levels were calculated as the ratio relative to that in WT cells. Results are presented as the mean ± SE. *P<0.05, 
significantly different from the WT group; †P<0.05, significantly different from the Nrf2-KO group; §P<0.05, significantly dif-
ferent from the p62-KO group.
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cells but not M2 phenotype Kupffer cells increased, as 
determined using flow cytometry for CD11c as a mark-
er for m1 macrophages and Cd206 as a marker for m2 
macrophages (Fig. 5A).
LPS polarizes macrophages towards the M1 pheno-
type. m1 macrophages are implicated in the initiation 
and maintenance of inflammation. To directly test the 
inflammatory response of Kupffer cells, Kupffer cells 
from WT, Nrf2-KO, p62-KO, and DKO mice at 8 weeks 
of age were isolated and stimulated with LPS ex vivo. 
Analysis using qrT-PCr revealed that upregulation of 
Tnf-α mRNA with vehicle treatment was only present in 
dKO mice, indicating innate immunity activation at an 
early age, and that the magnitude of the upregulation 
was further potentiated by LPS treatment (data not 
shown). There was no significant difference in the num-
ber of F4/80-positive cells, which is a surface marker of 
Kupffer cells (Supplementary Fig. 4).
Impairment of the phagocytic function of Kupffer cells 
may play a critical role in the development of nAsh 
[39, 44]. Therefore, the effects in the liver parenchymal 
phase were determined by SPIO-MRI, and Kupffer cell 
phagocytic activity was assessed in mice. The magnitude 
of changes in the T2 value of the liver parenchymal 
phase, which reflects the Kupffer cell phagocytic status 
of SPIO, was smaller in Nrf2-KO, p62-KO, and dKO 
mice than in WT mice (Fig. 5b). simply put, the phago-
cytic ability decreased in these mice. When the ability 
of F4/80-positive cells to uptake latex beads was inves-
tigated by flow cytometry, the bead phagocytic ability 
was lower in Nrf2-KO and dKO mice than in WT and 
p62-KO mice (Fig. 5C). Correlating with these findings, 
the positive fraction of mArCO, a scavenger receptor, 
decreased in Nrf2-KO and DKO mice. There was no 
significant difference observed for the positive fraction 
of sr-A (Fig. 5C).
As noted, macrophages polarizing towards the M1 
phenotype and innate immunity were activated in the 
livers of DKO mice at 8 weeks of age. The findings 
suggest that the Kupffer cells of DKO mice due to their 
genetic background accelerate the inflammatory response 
to excessive LPS flux through an increase in the suscep-
tibility of innate immunity to LPs. We produced 
rAW264.7 lacking the p62 or Nrf2 gene using the 
CrisPr-Cas9 system. In vitro experiments were con-
ducted to evaluate the inflammatory response to LPS. 
Expression of p62 and Nrf2 protein in each gene-defi-
cient cell was confirmed by immunoblot analysis (Fig. 
5D). Analysis showed that phosphorylation of Nuclear 
factor-kappa B p65 (NF-κB p65) increased in Nrf2-de-
ficient cells compared with WT cells (Fig. 5E). Interest-
ingly, Tnf-α and IL-1β mRNA expression levels follow-
ing treatment with low-dose LPS were also upregulated 
in Nrf2-deficient cells compared with WT cells (Fig. 5F).
Diet restriction improved NASH in DKO mice
To confirm the association between hyperphagia-in-
duced obesity and nAsh development in dKO mice, 
diet restriction by pair-feeding was conducted using 
dKO mice. Pair-feeding restricted the intake of standard 
chow to 3.0 ± 0.1 g/day/mouse. DKO mice subjected to 
diet restriction showed a body weight gain curve similar 
to WT mice fed ad libitum (Fig. 6A). When compared 
with ad libitum DKO mice with liver steatosis, inflam-
mation, and fibrosis, pair-feed DKO mice showed dra-
matic improvements in these pathological conditions in 
the liver (Figs. 6b and C). improvements in nAsh 
conditions were coupled with recovered intestinal per-
meability (Fig. 6d) and improved microbiota composi-
tion (e.g., a decreased proportion of gram-negative 
bacteria and decreased fecal LPs concentrations) (Fig. 
6E) and thereby decreased serum LPs concentrations 
(Fig. 6F).
Discussion
The major findings of this study are that p62 defi-
ciency resulted in hyperphagia-induced obesity coupled 
with insulin resistance and adipokine imbalance as well 
as dysbiosis and that Nrf2 deficiency resulted in intesti-
nal barrier dysfunction and an accelerated inflammatory 
response to LPS in Kupffer cells. Both defects resulted 
in the onset and progression of NASH and were associ-
ated with hepatic tumorigenesis in DKO mice fed a 
normal diet. However, p62 or Nrf2 single gene-knockout 
mice did not progress to nAsh.
Of note, in dKO mice, a high-fat diet is not needed 
for the development of NASH. In this regard, inflamma-
tory events may lead to fat accumulation (steatosis) in 
the livers [26]. As proposed by the multiple parallel hits 
theory, which is currently accepted as the pathogenesis 
of nonalcoholic fatty liver disease (NAFLD) [38], in-
flammatory mediators from the intestines (e.g., LPS) and 
adipose tissue (e.g., adipokines) could play a central role 
in the cascade of hepatic inflammation and fibrosis de-
velopment. it is possible that, in dKO mice, activation 
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of innate immunity by an excessive LPS flux, occurring 
both within and outside the liver, is a central pathway 
that regulates the development of hepatic damage in the 
form of nAsh.
Cumulative data suggests that dysbiosis of the intes-
tinal microbiota is associated with the onset and progres-
sion of NASH [9]. Several studies have reported that 
serum LPs levels are elevated in nAFLd patients com-
pared with controls [14, 25]. The fecal microbiota in 
nAFLd or nAsh patients has been assessed using 
culture-independent techniques such as sequencing of a 
conserved region in the bacterial 16s rrnA gene. mi-
crobiota samples from patients with NAFLD or NASH 
have a higher proportion of members of the Porphyro-
Fig. 6. diet restriction improved nonalcoholic steatohepatitis (nAsh) in p62:Nrf2 gene double-knockout (dKO) mice. (A) 
Body weight changes in wild-type (WT), ad libitum DKO, and pair-feeding mice (n=10–15 per group). (B) Hematoxy-
lin and eosin (h&E)- and sirius red-stained sections of representative liver specimens from the ad libitum dKO and 
pair-feeding groups at 30 weeks of age (scale bar, 100 µm). (C) The steatosis, activity, and fibrosis (SAF) scores for 
each group are shown (8 per group). (D) Area under the plasma concentration curve of fluorescein isothiocyanate (FITC)-
dextran in plasma after administration of the marker by gavage (n=8 per group). (E) The relative abundance of gram-
negative bacteria was calculated as the percentage of bacteria relative to the total bacteria for fecal bacteria (n=8 per 
group). (F) Fecal and serum lipopolysaccharide (LPs) levels in WT, ad libitum DKO, and pair-feeding mice (n=8 per 
group). results are presented as the mean ± sE. *P<0.05, significantly different from the ad libitum dKO group.
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monadaceae family and a lower proportion of members 
of the Lachnospiraceae and Ruminococcaceae families 
than those from healthy people [42, 47]. Flora analysis 
of DKO mice in the current study showed an increased 
proportion of Porphyromonadaceae and decreased pro-
portions of Lachnospiraceae and Ruminococcaceae (Fig. 
3). Because we compared proportions of microflora, it 
is impossible to accurately compare the number of bac-
teria. The fecal LPS concentration was elevated in both 
p62-KO and DKO mice. However, serum LPS concentra-
tions were elevated only in DKO mice. Interestingly, diet 
restriction by pair-feeding decreased fecal and serum 
LPS concentrations in DKO mice, which in turns re-
sulted in an improvement in the hepatic conditions of 
nAsh (Fig. 6). moreover, administration of the probi-
otic VSL#3 from 10 to 25 weeks of age increased the 
bacterial species Bifidobacterium infantis and Strepto-
coccus thermophilus in feces and reduced serum LPs 
concentrations (supplemental Figs. 5A and 5b). in ad-
dition, steatosis, inflammation, and fibrosis were im-
proved in the liver (supplemental Fig. 5C). From these 
results, it is suggested that p62 deficiency in DKO mice 
modifies the intestinal flora (e.g., increasing the propor-
tion of gram-negative bacteria) through hyperphagia and 
thereby increases fecal LPs concentrations. in addition, 
the activation of TLr4 by LPs from intestinal gram-
negative bacteria has recently been shown to promote 
the development of hepatocellular carcinoma [6]. There-
fore, it is likely that in dKO mice LPs is closely in-
volved in the liver tumorigenesis, since the expression 
levels of genes downstream of TLR4 were increased in 
the liver (Table 1).
Previous studies suggest a pathological link between 
intestinal permeability status and nAsh. it is reported 
that the intestinal microbiome is perturbed in both peo-
ple with obesity and NAFLD patients, which in turn may 
lead to increased fecal LPs levels and result in leaky gut 
[41]. Luca et al. reported that intestinal permeability is 
increased in patients with NAFLD and that the staining 
intensity of Zo-1 in the intestinal epithelia significantly 
decreases in patients with NAFLD [30]. The results of 
the current study (Fig. 4) indicate that both Nrf2 defi-
ciency in mice and Nrf2 deletion in Caco-2 cells con-
tribute to increased intestinal permeability through a 
decrease in zo-1 expression levels, suggesting that nrf2 
is closely involved in the maintenance of intestinal bar-
rier function. In addition, Nrf2 is known to inhibit the 
expression levels of i-nitric oxide synthase [27]. There-
fore, in the damaged intestines of dKO mice (Fig. 4), 
an LPs-induced increase in inducible nO synthase activ-
ity may also be an important factor responsible for the 
increased permeability as reported previously [11].
Obesity is an inflammatory condition characterized 
by increased activity of the innate immune system. in-
creased sensitivity of the liver to LPS in people with 
obesity is closely associated with the pathogenesis of 
NASH [43]. Understanding the role of Kupffer cells in 
the context of inflammation in the pathogenetic process 
of LPs-induced liver injury has recently increased. 
imajo et al. demonstrated that obesity-associated in-
creases in leptin levels result in an increased sensitivity 
of Kupffer cells to low doses of LPS through increased 
expression of Cd14, a receptor for LPs and LPs-binding 
protein complexes [16]. In the current study, increased 
leptin levels in DKO mice at 8 and 30 weeks of age were 
associated with increased expression levels of pro-in-
flammatory cytokines in the liver at 8 and 30 weeks of 
age and those in visceral fat at 30 weeks of age (Table 
1).
Activation of innate immunity may play a role in the 
pathophysiology of inflammation-induced liver damage. 
Kupffer cells play an important role in innate immunity. 
Macrophages (Kupffer cells) undergo specific differen-
tiation depending on the local tissue environment, re-
sponding to environmental cues within tissues such as 
damaged cells or microbial products to differentiate into 
distinct functional phenotypes. in the current study, phe-
notypic changes in Kupffer cells were observed in DKO 
mice (Fig. 5), with the proportion of M1 phenotype 
Kupffer cells increasing. The M1 macrophage phenotype, 
which is characterized by the production of high levels 
of pro-inflammatory cytokines and high production of 
reactive nitrogen and oxygen intermediates, is impli-
cated in initiation and maintenance of inflammation. 
Therefore, the phenotypic changes are thought to wors-
en the hepatic conditions of NASH [1].
The responsiveness of cultured macrophages to low 
doses of LPS increased with Nrf2 deletion in the current 
study (Fig. 5). Activation of nrf2 prevents LPs-induced 
upregulation of pro-inflammatory cytokines [22]. There-
fore, an increased inflammatory response to low doses 
of LPs in Nrf2 deficiency and hyperleptinemia in p62 
deficiency are closely associated with maintenance of 
inflammation in the livers of DKO mice.
In this study, the phagocytic ability of Kupffer cells 
decreased in DKO mice. Flow cytometry revealed that 
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Nrf2 deficiency reduced the expression level of MARCO 
as a scavenger receptor and decreased the phagocytic 
ability of Kupffer cells (Fig. 5). In humans and rats, im-
paired phagocytic functions of Kupffer cells are causa-
tively associated with the development of NASH [39]. 
mArCO restricts TLr4 responses to LPs, and expres-
sion levels of MARCO increase when LPS is adminis-
tered [31]. Therefore, decreased expression of MARCO 
in DKO mice may increase the TLR4 response to low 
doses of LPs.
several studies have reported the involvement of p62 
and nrF2 in human nAsh. p62 is a component of 
Mallory-Denk bodies, which are protein aggregates that 
accumulate in damaged liver cells in nAsh, cirrhosis, 
and HCC [36]. Impaired autophagic flux is associated 
with increased endoplasmic reticulum stress during the 
development of nAsh, and consequently, levels of he-
patic p62 protein are significantly increased in patients 
with NASH compared with those in control subjects [10]. 
in contrast, duran et al. showed that p62 expression was 
significantly lower in tumoral hepatic stellate cells, caus-
ing impaired repression of fibrosis and inflammation [8]. 
Activation of nrF2 is also observed in human nAsh 
[13, 21], indicating that NRF2 plays an important role 
in adaptation to oxidative stress in nAsh and tumors. 
These reports indicate that p62 and nrF2 may have 
important roles in human nAsh progression.
in conclusion, feeding of a standard diet to dKO mice 
resulted in the development of NASH and was associ-
ated with tumorigenesis. In vivo and in vitro studies 
revealed that p62 deficiency resulted in hyperphagia-
induced obesity coupled with insulin resistance and 
adipokine imbalance as well as dysbiosis (e.g., an in-
creased proportion of gram-negative bacteria) and that 
Nrf2 deficiency resulted in intestinal barrier dysfunction 
and an accelerated inflammatory response to LPS in 
Kupffer cells. In mice, activation of innate immunity by 
excessive LPS flux, occurring both within and outside 
the liver (e.g., intestines and visceral adipose tissue), is 
central to the development of hepatic damage in the form 
of nAsh (Fig. 7). because of the phenotypic similarities 
to the clinical features of human nAsh, e.g., obesity 
(visceral fat accumulation) coupled with metabolic syn-
drome, insulin resistance, and adipokine imbalance, 
dKO mice represent a unique animal model for inves-
tigating the pathogenesis of human nAsh and exploring 
novel targets for the prevention and/or treatment of 
nAsh. A therapeutic approach targeting the intestinal 
flora and intestinal barrier function with probiotics may 
be useful for the potential management of nAsh.
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